We are live on
!
Find out more
PP
PDT Partners Portfolio holdings
AUM
$1.69B
1-Year Est. Return
74.01%
This Fund
S&P 500
This Quarter
Est. Return
-9.73%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$4.47B
AUM Growth
+$642M
(+17%)
Cap. Flow
+$1.21B
Cap. Flow
% of AUM
27.16%
Top 10 Holdings %
Top 10 Hldgs %
10.34%
Holding
1,839
New
528
Increased
414
Reduced
278
Closed
614
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viatris
VTRS
|
+$73M |
| 2 |
Sherwin-Williams
SHW
|
+$64.9M |
| 3 |
Amgen
AMGN
|
+$55.9M |
| 4 |
Merck
MRK
|
+$48M |
| 5 |
eBay
EBAY
|
+$41.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$50.9M |
| 2 |
Ambarella
AMBA
|
+$36.8M |
| 3 |
Lumen
LUMN
|
+$33.8M |
| 4 |
Medtronic
MDT
|
+$33.7M |
| 5 |
Hilton Worldwide
HLT
|
+$29.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.88% |
| 2 | Consumer Discretionary | 16.77% |
| 3 | Technology | 12.78% |
| 4 | Industrials | 9.33% |
| 5 | Financials | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SVA
1201
DELISTED
Sinovac Biotech, Ltd
SVA
| $136K | ﹤0.01% |
26,700
+3,400
| +15% | +$18K |
|
|
ECYT
1202
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $128K | ﹤0.01% |
+27,900
| New | +$146K |
|
|
ELOS
1203
DELISTED
Syneron Medical Ltd
ELOS
| $124K | ﹤0.01% |
17,348
-494
| -3% | -$4.75K |
|
1204
Allot
ALLT
$373M
| $122K | ﹤0.01% |
24,900
+2,900
| +13% | +$15.3K |
|
|
WSR
1205
DELISTED
Whitestone REIT
WSR
| $121K | ﹤0.01% |
+10,532
| New | +$130K |
|
|
ACRE
1206
Ares Commercial Real Estate
ACRE
$257M
| $120K | ﹤0.01% |
+10,044
| New | +$123K |
|
|
VDTH
1207
DELISTED
Videocon d2h Limited
VDTH
| $120K | ﹤0.01% |
+12,433
| New | +$143K |
|
|
SHOR
1208
DELISTED
ShoreTel, Inc.
SHOR
| $120K | ﹤0.01% |
+16,106
| New | +$116K |
|
|
EVDY
1209
DELISTED
Everyday Health, Inc.
EVDY
| $112K | ﹤0.01% |
+12,240
| New | +$134K |
|
|
SYUT
1210
DELISTED
Synutra International, Inc.
SYUT
| $107K | ﹤0.01% |
22,442
+8,342
| +59% | +$47.8K |
|
|
ORC
1211
Orchid Island Capital
ORC
$1.3B
| $105K | ﹤0.01% |
2,260
-3,986
| -64% | -$183K |
|
|
PVG
1212
DELISTED
PRETIUM RESOURCES INC.
PVG
| $105K | ﹤0.01% |
+17,287
| New | +$89.1K |
|
1213
TriplePoint Venture Growth BDC
TPVG
$182M
| $104K | ﹤0.01% |
+10,252
| New | +$125K |
|
|
GCAP
1214
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $103K | ﹤0.01% |
+14,200
| New | +$111K |
|
1215
AES
AES
$10.6B
| $100K | ﹤0.01% |
+10,200
| New | +$123K |
|
|
MRNS
1216
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $98K | ﹤0.01% |
+2,950
| New | +$166K |
|
1217
Commercial Vehicle Group
CVGI
$154M
| $96K | ﹤0.01% |
23,800
+9,400
| +65% | +$49.8K |
|
1218
Mitsubishi UFJ Financial
MUFG
$260B
| $90K | ﹤0.01% |
14,700
-126,300
| -90% | -$855K |
|
1219
Acco Brands
ACCO
$381M
| $85K | ﹤0.01% |
+12,080
| New | +$90.6K |
|
1220
FormFactor
FORM
$7.7B
| $78K | ﹤0.01% |
+11,469
| New | +$80.1K |
|
1221
EyePoint Inc
EYPT
$1.04B
| $70K | ﹤0.01% |
1,910
+260
| +16% | +$10.2K |
|
1222
Harmonic Inc
HLIT
$1.23B
| $61K | ﹤0.01% |
+10,500
| New | +$63.9K |
|
|
IMN
1223
DELISTED
Imation
IMN
| $51K | ﹤0.01% |
23,860
+3,660
| +18% | +$12.2K |
|
|
SQNM
1224
DELISTED
SEQUENOM INC NEW
SQNM
| $46K | ﹤0.01% |
26,101
-155,099
| -86% | -$380K |
|
|
MRIN
1225
DELISTED
Marin Software
MRIN
| $45K | ﹤0.01% |
340
-443
| -57% | -$84.2K |
|
Similar funds
ISS
GAM
BCM
FACM
TCBWMS
WAS
SGI
AAM
PDT Partners's Q3 2015 Portfolio in Review
As of Q3 2015, PDT Partners held 1,839 positions worth $4.47B, up 17% from $3.82B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
PDT Partners deployed $1.21B of net new capital in Q3 2015, opening 528 new positions and adding to 414 existing holdings. Its largest new stake was Viatris: 1,310,084 shares worth $52.7M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Ambarella, an estimated $36.8M trimmed.
- PDT Partners's largest Q3 2015 buy was Viatris: 1,310,084 shares worth $52.7M.
- PDT Partners added most to Sherwin-Williams in Q3 2015, an estimated $64.9M increase.
- PDT Partners's biggest Q3 2015 reduction was Ambarella, cutting an estimated $36.8M.
- PDT Partners fully exited Coca-Cola in Q3 2015, selling an estimated $50.9M.
- PDT Partners's ten largest holdings make up 10% of its $4.47B portfolio in Q3 2015.
- PDT Partners opened 528 new positions and closed 614 in Q3 2015.
- PDT Partners's portfolio value rose 17% quarter-over-quarter to $4.47B.
Based on PDT Partners's 13F filing for Q3 2015, filed 16 Nov 2015.